CTRI/2010/091/000145已完成3 期
A trial investigating the efficacy and safety of NN1250 compared to insulin detemir in subjects with type 1 diabetes mellitus in a basal/bolus treatment regimen (BEGIN?: BB T1)
ovo Nordisk AS0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Type 1 diabetes mellitus for at least 12 months
- •Current treatment with any basal bolus insulin for at least 12 months
- •HbA1c below or equal to 10.0 %
- •BMI (body mass index) below or equal to 35.0 kg/m2
- •Age 18 years and older
排除标准
- •Use of any other antidiabetic drug than insulin within the last 3 months
- •Cardiovascular disease within the last 6 months
- •Uncontrolled treated/untreated severe hypertension
- •Recurrent severe hypoglycemia or hypoglycemic unawareness or hospitalisation for diabetic ketoacidosis during the previous 6 months
- •Pregnancy, breast-feeding, the intention of becoming pregnant or not using adequate contraceptive measures
- •Cancer and medical history of cancer
研究者
相似试验
进行中（未招募）
不适用
A trial investigating the efficacy and safety of NN1250 compared to insulin detemir in subjects with type 1 diabetes mellitus in a basal/bolus treatment regimetype 1 diabetes mellitusEUCTR2009-011672-29-FIovo Nordisk A/S426
进行中（未招募）
不适用
A trial investigating the efficacy and safety of NN1250 compared to insulin detemir in subjects with type 1 diabetes mellitus in a basal/bolus treatment regimen - BEGIN : BB T1type 1 diabetesEUCTR2009-011672-29-ITOVO NORDISK426
进行中（未招募）
1 期
A trial investigating the efficacy and safety of NN1250 compared to insulin detemir in subjects with type 1 diabetes mellitus in a basal/bolus treatment regimeMedDRA version: 12.0 Level: LLT Classification code 10045228 Term: Type I diabetes mellitustype 1 diabetes mellitusEUCTR2009-011672-29-GBovo Nordisk A/S
进行中（未招募）
不适用
A trial investigating the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals versus insulin detemir once or twice daily plus meal time insulin aspart in children and adolescents with type 1 diabetes mellitusDiabetes Mellitus, Type 1EUCTR2012-003566-41-BEovo Nordisk A/S346
进行中（未招募）
不适用
A trial investigating the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals versus insulin detemir once or twice daily plus meal time insulin aspart in children and adolescents with type 1 diabetes mellitusDiabetes Mellitus, Type 1MedDRA version: 16.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusSystem Organ Class: 100000004861EUCTR2012-003566-41-SIovo Nordisk A/S346